![](/img/cover-not-exists.png)
Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials
Huang, Feng, Luo, Zu-chunLanguage:
english
Journal:
Clinical Rheumatology
DOI:
10.1007/s10067-018-4299-4
Date:
September, 2018
File:
PDF, 2.28 MB
english, 2018